Skip to main content
Top
Published in: Gastric Cancer 1/2021

01-01-2021 | Gastrectomy | Original Article

Preservation of hepatic branch of the vagus nerve reduces the risk of gallstone formation after gastrectomy

Authors: Chao-Jie Wang, Seong-Ho Kong, Ji-Hyeon Park, Jong-Ho Choi, Shin-Hoo Park, Chun-Chao Zhu, Fadhel Alzahrani, Khalid Alzahrani, Yun-Suhk Suh, Do-Joong Park, Hyuk-Joon Lee, Hui Cao, Han-Kwang Yang

Published in: Gastric Cancer | Issue 1/2021

Login to get access

Abstract

Background

Injury to the vagus nerve has been proposed to be associated with occurrence of gallstones after gastrectomy. We investigated the effect of preservation of hepatic branch of the vagus nerve on prevention of gallstones during laparoscopic distal (LDG) and pylorus-preserving gastrectomy (LPPG).

Methods

Preservation of the vagus nerve was reviewed of cT1N0M0 gastric cancer patients underwent LDG (n = 323) and LPPG (n = 144) during 2016–2017. Presence of gallstones was evaluated by ultrasonography (US) and computed tomography (CT). Incidences of gallstones were compared between the nerve preserved (h-DG, h-PPG) group and sacrificed (s-DG, s-PPG) group. Clinicopathological features were also compared.

Results

The 3-year cumulative incidence of gallstones was lower in the h-DG (2.7%, n = 85) than the s-DG (14.6%, n = 238) (p = 0.017) and lower in the h-PPG (1.6%, n = 123) than the s-PPG (12.9%, n = 21) (p = 0.004). Overall postoperative complication rate was similar between the h-DG and s-DG (p = 0.861) as well as between the h-PPG and s-PPG (p = 0.768). The number of retrieved lymph nodes station #1 and 3-year recurrence-free survival were not significantly different between the preserved group and sacrificed group. Injury to the vagus nerve (p = 0.001) and high body mass index (BMI) (≥ 27.5 kg/m2) (p = 0.040) were found to be independent risk factors of gallstone formation in multivariate analysis.

Conclusions

Preservation of hepatic branch of the vagus nerve can be recommended for LDG as well as LPPG of early gastric cancer patients to reduce postoperative gallstone formation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.PubMed
2.
go back to reference Hamashima C, Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2018;48:673–83.CrossRefPubMed Hamashima C, Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2018;48:673–83.CrossRefPubMed
3.
go back to reference Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. 2017;152:1319–28.CrossRefPubMed Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. 2017;152:1319–28.CrossRefPubMed
4.
go back to reference Wang S, Yu S, Xu J, Zhao G. Valuation and prospect of function preserving gastrectomy. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:1141–4.PubMed Wang S, Yu S, Xu J, Zhao G. Valuation and prospect of function preserving gastrectomy. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:1141–4.PubMed
7.
go back to reference Shinohara H, Sonoda T, Niki M, Nomura E, Nishiguchi K, Tanigawa N. Laparoscopically-assisted pylorus-preserving gastrectomy with preservation of the vagus nerve. Eur J Surg. 2002;168:55–8.CrossRefPubMed Shinohara H, Sonoda T, Niki M, Nomura E, Nishiguchi K, Tanigawa N. Laparoscopically-assisted pylorus-preserving gastrectomy with preservation of the vagus nerve. Eur J Surg. 2002;168:55–8.CrossRefPubMed
9.
go back to reference Seo GH, Lim CS, Chai YJ. Incidence of gallstones after gastric resection for gastric cancer: a nationwide claims-based study. Ann Surg Treat Res. 2018;95:87–93.CrossRefPubMed Seo GH, Lim CS, Chai YJ. Incidence of gallstones after gastric resection for gastric cancer: a nationwide claims-based study. Ann Surg Treat Res. 2018;95:87–93.CrossRefPubMed
10.
go back to reference Park DJ, Kim KH, Park YS, Ahn SH, Park do J, Kim HH. Risk factors for gallstone formation after surgery for gastric cancer. J Gastric Cancer. 2016;16:98–104.CrossRefPubMedPubMedCentral Park DJ, Kim KH, Park YS, Ahn SH, Park do J, Kim HH. Risk factors for gallstone formation after surgery for gastric cancer. J Gastric Cancer. 2016;16:98–104.CrossRefPubMedPubMedCentral
12.
go back to reference Liang TJ, Liu SI, Chen YC, Chang PM, Huang WC, Chang HT, et al. Analysis of gallstone disease after gastric cancer surgery. Gastric Cancer. 2017;20:895–903.CrossRefPubMed Liang TJ, Liu SI, Chen YC, Chang PM, Huang WC, Chang HT, et al. Analysis of gallstone disease after gastric cancer surgery. Gastric Cancer. 2017;20:895–903.CrossRefPubMed
13.
go back to reference Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg. 2005;92:1399–403.CrossRefPubMed Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y. Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg. 2005;92:1399–403.CrossRefPubMed
15.
go back to reference Hashimoto M, Imamura T, Tamura T, Koyama R, Koizumi Y, Makuuchi M, et al. Treatment of biliary tract stones after gastrectomy in the era of laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci. 2016;23:703–7.CrossRefPubMed Hashimoto M, Imamura T, Tamura T, Koyama R, Koizumi Y, Makuuchi M, et al. Treatment of biliary tract stones after gastrectomy in the era of laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci. 2016;23:703–7.CrossRefPubMed
16.
go back to reference Wang M, Zhang T, Peng C. Laparoscopic cholecystectomy with previous gastrectomy. J Invest Surg. 2013;26:96–8.CrossRefPubMed Wang M, Zhang T, Peng C. Laparoscopic cholecystectomy with previous gastrectomy. J Invest Surg. 2013;26:96–8.CrossRefPubMed
17.
go back to reference Yamamoto H, Hayakawa N, Yamamoto T, Momiyama M, Nagino M. Laparoscopic cholecystectomy in patients with a previous history of gastrectomy. Hepatogastroenterology. 2013;60:443–6.PubMed Yamamoto H, Hayakawa N, Yamamoto T, Momiyama M, Nagino M. Laparoscopic cholecystectomy in patients with a previous history of gastrectomy. Hepatogastroenterology. 2013;60:443–6.PubMed
18.
go back to reference Zhang M, Zhang J, Sun X, Xu J, Zhu J, Yuan W, et al. Clinical analysis of treatment strategies to cholecystocholedocholithiasis patients with previous subtotal or total gastrectomy: a retrospective cohort study. BMC Surg. 2018;18:54.CrossRefPubMedPubMedCentral Zhang M, Zhang J, Sun X, Xu J, Zhu J, Yuan W, et al. Clinical analysis of treatment strategies to cholecystocholedocholithiasis patients with previous subtotal or total gastrectomy: a retrospective cohort study. BMC Surg. 2018;18:54.CrossRefPubMedPubMedCentral
19.
go back to reference Chen Y, Li Y. Related factors of postoperative gallstone formation after distal gastrectomy: a meta-analysis. Indian J Cancer. 2017;54:43–6.CrossRefPubMed Chen Y, Li Y. Related factors of postoperative gallstone formation after distal gastrectomy: a meta-analysis. Indian J Cancer. 2017;54:43–6.CrossRefPubMed
20.
go back to reference Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group and Review Panel. Korean practice guideline for gastric cancer: an evidence-based, multi-disciplinary approach. J Gastric Cancer. 2018;2019(19):1–48. Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group and Review Panel. Korean practice guideline for gastric cancer: an evidence-based, multi-disciplinary approach. J Gastric Cancer. 2018;2019(19):1–48.
21.
go back to reference Tsujiura M, Hiki N, Ohashi M, Nunobe S, Kumagai K, Ida S, et al. Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer? Gastric Cancer. 2019;22:1247–55.CrossRefPubMed Tsujiura M, Hiki N, Ohashi M, Nunobe S, Kumagai K, Ida S, et al. Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer? Gastric Cancer. 2019;22:1247–55.CrossRefPubMed
22.
go back to reference Suh YS, Han DS, Kong SH, Kwon S, Shin CI, Kim WH, et al. Laparoscopy-assisted pylorus-preserving gastrectomy is better than laparoscopy-assisted distal gastrectomy for middle-third early gastric cancer. Ann Surg. 2014;259:485–93.CrossRefPubMed Suh YS, Han DS, Kong SH, Kwon S, Shin CI, Kim WH, et al. Laparoscopy-assisted pylorus-preserving gastrectomy is better than laparoscopy-assisted distal gastrectomy for middle-third early gastric cancer. Ann Surg. 2014;259:485–93.CrossRefPubMed
23.
go back to reference Eom BW, Park B, Yoon HM, Ryu KW, Kim YW. Laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer: a retrospective study of long-term functional outcomes and quality of life. World J Gastroenterol. 2019;25:5494–504.CrossRefPubMedPubMedCentral Eom BW, Park B, Yoon HM, Ryu KW, Kim YW. Laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer: a retrospective study of long-term functional outcomes and quality of life. World J Gastroenterol. 2019;25:5494–504.CrossRefPubMedPubMedCentral
24.
go back to reference Zhu CC, Cao H, Berlth F, Xu J, Park SH, Choe HN, et al. Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher? Gastric Cancer. 2019;22:881–91.CrossRefPubMed Zhu CC, Cao H, Berlth F, Xu J, Park SH, Choe HN, et al. Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher? Gastric Cancer. 2019;22:881–91.CrossRefPubMed
25.
go back to reference Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRefPubMed
26.
go back to reference Nunobe S, Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer. Gastric Cancer. 2007;10:167–72.CrossRefPubMed Nunobe S, Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer. Gastric Cancer. 2007;10:167–72.CrossRefPubMed
27.
go back to reference Jiang X, Hiki N, Nunobe S, Fukunaga T, Kumagai K, Nohara K, et al. Postoperative outcomes and complications after laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer. Ann Surg. 2011;253:928–33.CrossRefPubMed Jiang X, Hiki N, Nunobe S, Fukunaga T, Kumagai K, Nohara K, et al. Postoperative outcomes and complications after laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer. Ann Surg. 2011;253:928–33.CrossRefPubMed
28.
go back to reference Kiyokawa T, Hiki N, Nunobe S, Honda M, Ohashi M, Sano T. Preserving infrapyloric vein reduces postoperative gastric stasis after laparoscopic pylorus-preserving gastrectomy. Langenbecks Arch Surg. 2017;402:49–56.CrossRefPubMed Kiyokawa T, Hiki N, Nunobe S, Honda M, Ohashi M, Sano T. Preserving infrapyloric vein reduces postoperative gastric stasis after laparoscopic pylorus-preserving gastrectomy. Langenbecks Arch Surg. 2017;402:49–56.CrossRefPubMed
29.
go back to reference Masclee AA, Jansen JB, Driessen WM, Geuskens LM, Lamers CB. Delayed plasma cholecystokinin and gallbladder responses to intestinal fat in patients with Billroth I and II gastrectomy. Surgery. 1989;106:502–8.PubMed Masclee AA, Jansen JB, Driessen WM, Geuskens LM, Lamers CB. Delayed plasma cholecystokinin and gallbladder responses to intestinal fat in patients with Billroth I and II gastrectomy. Surgery. 1989;106:502–8.PubMed
30.
go back to reference Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, et al. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology. 1987;7:913–7.CrossRefPubMed Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, et al. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology. 1987;7:913–7.CrossRefPubMed
31.
go back to reference Furukawa H, Ohashi M, Honda M, Kumagai K, Nunobe S, Sano T, et al. Preservation of the celiac branch of the vagal nerve for pylorus-preserving gastrectomy: is it meaningful? Gastric Cancer. 2018;21:516–23.CrossRefPubMed Furukawa H, Ohashi M, Honda M, Kumagai K, Nunobe S, Sano T, et al. Preservation of the celiac branch of the vagal nerve for pylorus-preserving gastrectomy: is it meaningful? Gastric Cancer. 2018;21:516–23.CrossRefPubMed
32.
go back to reference Fukagawa T, Katai H, Saka M, Morita S, Sano T, Sasako M. Gallstone formation after gastric cancer surgery. J Gastrointest Surg. 2009;13:886–9.CrossRefPubMed Fukagawa T, Katai H, Saka M, Morita S, Sano T, Sasako M. Gallstone formation after gastric cancer surgery. J Gastrointest Surg. 2009;13:886–9.CrossRefPubMed
33.
go back to reference Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodríguez G, Baptista H, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11:1653–7.CrossRefPubMedPubMedCentral Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodríguez G, Baptista H, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11:1653–7.CrossRefPubMedPubMedCentral
34.
go back to reference Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55:708–14.CrossRefPubMedPubMedCentral Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55:708–14.CrossRefPubMedPubMedCentral
35.
go back to reference Weikert C, Weikert S, Schulze MB, Pischon T, Fritsche A, Bergmann MM, et al. Presence of gallstones or kidney stones and risk of type 2 diabetes. Am J Epidemiol. 2010;171:447–54.CrossRefPubMed Weikert C, Weikert S, Schulze MB, Pischon T, Fritsche A, Bergmann MM, et al. Presence of gallstones or kidney stones and risk of type 2 diabetes. Am J Epidemiol. 2010;171:447–54.CrossRefPubMed
37.
go back to reference WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef
38.
go back to reference Kimura J, Kunisaki C, Takagawa R, Makino H, Ueda M, Ota M, et al. Is routine prophylactic cholecystectomy necessary during gastrectomy for gastric cancer? World J Surg. 2017;41:1047–53.CrossRefPubMed Kimura J, Kunisaki C, Takagawa R, Makino H, Ueda M, Ota M, et al. Is routine prophylactic cholecystectomy necessary during gastrectomy for gastric cancer? World J Surg. 2017;41:1047–53.CrossRefPubMed
39.
go back to reference Tan Z, Xie P, Qian H, Yao X. Clinical analysis of prophylactic cholecystectomy during gastrectomy for gastric cancer patients: a retrospective study of 1753 patients. BMC Surg. 2019;19:48.CrossRefPubMedPubMedCentral Tan Z, Xie P, Qian H, Yao X. Clinical analysis of prophylactic cholecystectomy during gastrectomy for gastric cancer patients: a retrospective study of 1753 patients. BMC Surg. 2019;19:48.CrossRefPubMedPubMedCentral
40.
go back to reference Kong SH, Kim SM, Kim DG, Park KH, Suh YS, Kim TH, et al. Intraoperative neurophysiologic testing of the perigastric vagus nerve branches to evaluate viability and signals along nerve pathways during gastrectomy. J Gastric Cancer. 2019;19:49–61.CrossRefPubMedPubMedCentral Kong SH, Kim SM, Kim DG, Park KH, Suh YS, Kim TH, et al. Intraoperative neurophysiologic testing of the perigastric vagus nerve branches to evaluate viability and signals along nerve pathways during gastrectomy. J Gastric Cancer. 2019;19:49–61.CrossRefPubMedPubMedCentral
Metadata
Title
Preservation of hepatic branch of the vagus nerve reduces the risk of gallstone formation after gastrectomy
Authors
Chao-Jie Wang
Seong-Ho Kong
Ji-Hyeon Park
Jong-Ho Choi
Shin-Hoo Park
Chun-Chao Zhu
Fadhel Alzahrani
Khalid Alzahrani
Yun-Suhk Suh
Do-Joong Park
Hyuk-Joon Lee
Hui Cao
Han-Kwang Yang
Publication date
01-01-2021
Publisher
Springer Singapore
Published in
Gastric Cancer / Issue 1/2021
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-020-01106-z

Other articles of this Issue 1/2021

Gastric Cancer 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.